Clinical Trials Browser

Phase 2 × Pluvicto × 30 days × Clear all

NCT06783348 2026-06-04

RENALUT

Phase 2 Recruiting

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

NCT06632977 2026-06-02

PREDICT

Phase 2 Recruiting

Prostatic Neoplasms

NCT05849298 2026-05-27

PSMACare

Phase 2 Active not recruiting

Prostatic Neoplasms